Vimarsana
Biggest News Aggregation in the World

Page 9 - Abilify Maintena News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abilify Maintena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abilify Maintena Today - Breaking & Trending Today

European Medicines Agency Commences Review of Aripiprazole 2-Month Long-Acting Injectable for the Maintenance Treatment of Schizophrenia in Adult Pati - Vimarsana News

European Medicines Agency Commences Review of Aripiprazole 2-Month Long-Acting Injectable for the Maintenance Treatment of Schizophrenia in Adult Pati

European Medicines Agency Commences Review of Aripiprazole 2-Month Long-Acting Injectable for the Maintenance Treatment of Schizophrenia in Adult Patients Stabilised with AripiprazoleOtsuka Pharmaceutical Europe Ltd. (“Otsuka”) and H. Lundbeck A/S (“Lundbeck”) today announce that the European...

H. Lundbeck A/S (OTCMKTS:HLUYY) Stock Rating Lowered by Zacks Investment Research - Vimarsana News

H. Lundbeck A/S (OTCMKTS:HLUYY) Stock Rating Lowered by Zacks Investment Research

H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Monday, Zacks.com reports. According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the […]

Telepsychiatry Sessions Sufficient for Managing Schizophrenia - Vimarsana News

Telepsychiatry Sessions Sufficient for Managing Schizophrenia

'Clinics were very creative' during the pandemic, researcher says

Viatris Inc.'s (VTRS) CEO Michael Goettler on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Viatris Inc.'s (VTRS) CEO Michael Goettler on Q1 2022 Results - Earnings Call Transcript

Viatris Inc. (NASDAQ:NASDAQ:VTRS) Q1 2022 Earnings Conference Call May 9, 2022, 8:30 AM ET Company Participants Bill Szablewsk - Head, Global Capital Markets Michael Goettler - Chief...

Analyzing H. Lundbeck A/S (OTCMKTS:HLUYY) & Seven & i (OTCMKTS:SVNDY) - Vimarsana News

Analyzing H. Lundbeck A/S (OTCMKTS:HLUYY) & Seven & i (OTCMKTS:SVNDY)

H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) and Seven & i (OTCMKTS:SVNDY – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Dividends H. Lundbeck A/S pays an annual dividend […]